Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.030
-0.100 (-2.42%)
Nov 2, 2026, 3:02 PM EST - Market open
Taysha Gene Therapies Employees
Taysha Gene Therapies had 99 employees as of December 31, 2025. The number of employees increased by 26 or 35.62% compared to the previous year. That makes Taysha Gene Therapies the 31,596th largest employer in the world and 4,062nd in the United States.
Employees
99
Change (1Y)
26
Growth (1Y)
35.62%
Revenue / Employee
$55,404
Profits / Employee
-$1,511,444
Market Cap
1.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 26 | 35.62% |
| Dec 31, 2024 | 73 | 21 | 40.38% |
| Dec 31, 2023 | 52 | -13 | -20.00% |
| Dec 31, 2022 | 65 | -113 | -63.48% |
| Dec 31, 2021 | 178 | 140 | 368.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Kardigan | 241 |
| Omeros | 175 |
| AnaptysBio | 104 |
| Tyra Biosciences | 87 |
| GH Research | 73 |
| Savara | 70 |
| Nektar Therapeutics | 63 |
TSHA News
- 4 weeks ago - Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting - GlobeNewsWire
- 6 weeks ago - Taysha Gene Therapies initiated with an Outperform at Wolfe Research - TheFly
- 2 months ago - Taysha Gene Therapies Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Taysha Gene Therapies Earnings release: Q2 2026 - Filings
- 2 months ago - Taysha Gene Therapies Quarterly report: Q2 2026 - Filings
- 2 months ago - Taysha Gene Therapies reports Q2 EPS (13c), consensus (11c) - TheFly
- 2 months ago - Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire